Lpl Financial LLC Aim Immuno Tech Inc. Transaction History

Lpl Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.78 - $1.27 $390 - $635	-500 Reduced 3.03%	15,982 $12,000
Q3 2021 Nov 15, 2021	SELL	$1.91 - $2.17 $1,037 - $1,178	-543 Reduced 3.19%	16,482 $33,000
Q2 2021 Aug 13, 2021	BUY	$1.93 - $2.39 $1,013 - $1,254	525 Added 3.18%	17,025 $37,000
Q1 2021 May 14, 2021	BUY	$1.88 - $2.82 $7,520 - $11,280	4,000 Added 32.0%	16,500 $37,000
Q4 2020 Feb 12, 2021	SELL	$1.68 - $2.45 $13,440 - $19,600	-8,000 Reduced 39.02%	12,500 $22,000
Q3 2020 Nov 09, 2020	BUY	$1.77 - $3.88 $36,285 - $79,540	20,500 New	20,500 $44,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $9.61M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.